FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37262792> ?p ?o ?g. }

• Q37262792 description "article científic" @default.
• Q37262792 description "article scientifique" @default.
• Q37262792 description "articolo scientifico" @default.
• Q37262792 description "artigo científico" @default.
• Q37262792 description "artículu científicu espublizáu en 2010" @default.
• Q37262792 description "bilimsel makale" @default.
• Q37262792 description "scientific article published on 07 May 2010" @default.
• Q37262792 description "vedecký článok" @default.
• Q37262792 description "vetenskaplig artikel" @default.
• Q37262792 description "videnskabelig artikel" @default.
• Q37262792 description "vědecký článek" @default.
• Q37262792 description "wetenschappelijk artikel" @default.
• Q37262792 description "wissenschaftlicher Artikel" @default.
• Q37262792 description "наукова стаття, опублікована в травні 2010" @default.
• Q37262792 description "научни чланак" @default.
• Q37262792 description "مقالة علمية نشرت في 07 مايو 2010" @default.
• Q37262792 name "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 name "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 name "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 type Item @default.
• Q37262792 label "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 label "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 label "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 prefLabel "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 prefLabel "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 prefLabel "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 P1433 Q37262792-7AE6580F-3BEB-4392-885D-EFD82A4BCF80 @default.
• Q37262792 P1476 Q37262792-801233CE-D37E-40E0-8B32-8F421A1A5757 @default.
• Q37262792 P2093 Q37262792-135BCBA2-E279-4371-8165-AF70A7E03E0C @default.
• Q37262792 P2093 Q37262792-409330CC-1653-4F4C-BDB1-878F380E7DC3 @default.
• Q37262792 P2093 Q37262792-4DD72520-0761-4214-B6FA-5E1085A961A2 @default.
• Q37262792 P2093 Q37262792-73B756CD-08B5-44C7-8A56-4FD65CA81D17 @default.
• Q37262792 P2093 Q37262792-8E1AD7FA-0064-4685-875F-DF7A8ED1726E @default.
• Q37262792 P2093 Q37262792-98AE7D74-722D-4D77-A55A-33493076701E @default.
• Q37262792 P2093 Q37262792-B2AA4903-107C-4C2F-9479-227B25E709B3 @default.
• Q37262792 P2093 Q37262792-D98E689C-8E4A-43FF-A55C-A5F1D346848A @default.
• Q37262792 P2093 Q37262792-E0DBA56D-E579-446D-B048-A8498225A98A @default.
• Q37262792 P2093 Q37262792-F0B34269-DEE3-44C3-8C16-36D3392A1F76 @default.
• Q37262792 P2860 Q37262792-0547888C-81E1-4E3B-AE00-FA55954FE8D9 @default.
• Q37262792 P2860 Q37262792-06D7E7B0-6182-40BD-A2CB-A4767C352687 @default.
• Q37262792 P2860 Q37262792-0EABC579-F074-4E11-93F8-815AB11CBD92 @default.
• Q37262792 P2860 Q37262792-115D65D7-1C35-4C40-86BA-D4EA6FF6145B @default.
• Q37262792 P2860 Q37262792-20B73776-4075-4205-96E6-C1E76597E351 @default.
• Q37262792 P2860 Q37262792-240510CA-A596-4BBD-9BD9-F852FA3E727D @default.
• Q37262792 P2860 Q37262792-2ACCFAB2-49A9-4175-85B5-31CBF8DCD380 @default.
• Q37262792 P2860 Q37262792-2FD1F7F6-E10C-40C4-81D9-8CE9ED0F5864 @default.
• Q37262792 P2860 Q37262792-401C5DCB-C3D4-4F1E-AF68-9E8735390C1C @default.
• Q37262792 P2860 Q37262792-44F1BA44-D2B1-4956-A938-1D2185327DA9 @default.
• Q37262792 P2860 Q37262792-4BDA1F88-BD11-4BB4-AA62-B63899143166 @default.
• Q37262792 P2860 Q37262792-4DCBE55C-3087-48DB-ADE1-E7A0F68361B9 @default.
• Q37262792 P2860 Q37262792-5247C9A0-E61F-474C-A74B-183F30D60BAA @default.
• Q37262792 P2860 Q37262792-55F4C568-163B-47CF-94F3-775C9763A91F @default.
• Q37262792 P2860 Q37262792-68776F44-EBD8-4186-8903-9ED550E19389 @default.
• Q37262792 P2860 Q37262792-68AD0721-B379-47B2-9822-900F49A5BC6D @default.
• Q37262792 P2860 Q37262792-70B897AB-F943-4744-AE15-B801A6D8C839 @default.
• Q37262792 P2860 Q37262792-72D76079-EBC0-4E35-8615-174A9BBBD736 @default.
• Q37262792 P2860 Q37262792-748E77DA-F3C0-4BAE-A3A7-8E9447154D89 @default.
• Q37262792 P2860 Q37262792-85A60BE2-3BFD-4F98-B632-925CBB86953B @default.
• Q37262792 P2860 Q37262792-8660C7C4-6CC1-44A8-8240-1A0CB6B6B3BC @default.
• Q37262792 P2860 Q37262792-8E8FE08E-628E-4BB6-8B75-4B81975206B0 @default.
• Q37262792 P2860 Q37262792-932F9231-3C4F-4E65-8CA6-BAE750BFA8E4 @default.
• Q37262792 P2860 Q37262792-98A79BA2-A0A1-4601-9659-BA0C021AC45F @default.
• Q37262792 P2860 Q37262792-9EA57CF6-F734-4FC0-91BD-96C1FBC8D691 @default.
• Q37262792 P2860 Q37262792-9F076057-FE59-4306-A9D6-0C7733A400B4 @default.
• Q37262792 P2860 Q37262792-A878BB2E-E786-45CC-926B-285483BFEDE3 @default.
• Q37262792 P2860 Q37262792-AAB94262-CA8A-4EC1-8F9C-336C7A2E6057 @default.
• Q37262792 P2860 Q37262792-BBE43E10-ED0A-45C3-A7AA-F5F37FCBBBE5 @default.
• Q37262792 P2860 Q37262792-BEDA5ACB-B94D-4DE3-B662-01E3A8774793 @default.
• Q37262792 P2860 Q37262792-C47AD80A-5351-4F24-BF0E-91A24A4723AA @default.
• Q37262792 P2860 Q37262792-C60ED37E-2BF6-4737-9815-9CF9539EE5E0 @default.
• Q37262792 P2860 Q37262792-C869E98E-C319-49DC-B180-BBEE4E3E228B @default.
• Q37262792 P2860 Q37262792-D1698DA5-D7E1-48D9-9D2D-350228B53F50 @default.
• Q37262792 P2860 Q37262792-D7253C3A-A93E-4612-8F9C-00B57565B083 @default.
• Q37262792 P2860 Q37262792-E3173A59-F633-4C23-9909-12032219DC9C @default.
• Q37262792 P2860 Q37262792-FD6A1308-BED3-4A5D-93D2-5840662B789F @default.
• Q37262792 P2860 Q37262792-FDBD9C53-E1D8-4A6F-8486-BD36DAA9795B @default.
• Q37262792 P2860 Q37262792-FF778470-61E0-4188-A46D-888B7B3B4BBB @default.
• Q37262792 P2888 Q37262792-A6D99E0C-1DE5-4363-9F0C-55CBDDC3FA3A @default.
• Q37262792 P304 Q37262792-6DADD1ED-D142-454F-A52E-9D0F753B2120 @default.
• Q37262792 P31 Q37262792-7DA8D677-039C-4EF9-B385-8E2DCEBAB9F4 @default.
• Q37262792 P356 Q37262792-33B97BF9-51F9-4334-B98C-0A1F1C5EA165 @default.
• Q37262792 P433 Q37262792-21A03095-749F-49AF-8A67-941C4EA29D42 @default.
• Q37262792 P478 Q37262792-9EB26EE4-A9FE-4F9F-805E-458DE907865D @default.
• Q37262792 P50 Q37262792-D642C5EF-CF2F-49F9-88FC-53BBADA1D9AD @default.
• Q37262792 P50 Q37262792-F61C2A88-31E1-4ECB-9E70-57B8F5A863C1 @default.
• Q37262792 P577 Q37262792-EB0E2332-6C8F-4006-B69E-FB704F788E11 @default.
• Q37262792 P698 Q37262792-4AEC8CC2-2339-430C-96DB-6A6C1065A59D @default.
• Q37262792 P921 Q37262792-2C4F4135-DDEA-4E69-9853-3FDFE2EB8DEC @default.
• Q37262792 P921 Q37262792-3D1FB37A-3BCE-43FF-A4F8-D625C57817E2 @default.
• Q37262792 P921 Q37262792-54F0DF70-0EA8-48DC-A525-7D9075269ED3 @default.
• Q37262792 P921 Q37262792-9140C778-4FA4-44C1-9314-FFCF761E0BD6 @default.
• Q37262792 P932 Q37262792-9897F1F2-3DF8-4D57-AC41-5DB2B35CB8F9 @default.
• Q37262792 P356 S11060-010-0190-0 @default.
• Q37262792 P698 20449631 @default.
• Q37262792 P1433 Q15752119 @default.
• Q37262792 P1476 "A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas" @default.
• Q37262792 P2093 "David M Peereboom" @default.
• Q37262792 P2093 "Glenn Lesser" @default.
• Q37262792 P2093 "Jeffrey G Supko" @default.
• Q37262792 P2093 "Joy Fisher" @default.

• next